A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance

To cause disease, a microbial pathogen must adapt to the challenges of its host environment. The leading fungal pathogen Candida albicans colonizes nutrient-poor bodily niches, withstands attack from the immune system, and tolerates treatment with azole antifungals, often evolving resistance. To dis...

Full description

Bibliographic Details
Main Authors: Srinivas, Raja, Lancaster, Alex K., Scherz-Shouval, Ruth, Whitesell, Luke, Vincent, Benjamin Matteson, Langlois, Jean-Baptiste, Tidor, Bruce, Buchwald, Stephen Leffler, Lindquist, Susan
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: Elsevier 2017
Online Access:http://hdl.handle.net/1721.1/111146
https://orcid.org/0000-0002-3320-3969
https://orcid.org/0000-0003-3875-4775
https://orcid.org/0000-0003-1307-882X
_version_ 1811082605962985472
author Srinivas, Raja
Lancaster, Alex K.
Scherz-Shouval, Ruth
Whitesell, Luke
Vincent, Benjamin Matteson
Langlois, Jean-Baptiste
Tidor, Bruce
Buchwald, Stephen Leffler
Lindquist, Susan
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Srinivas, Raja
Lancaster, Alex K.
Scherz-Shouval, Ruth
Whitesell, Luke
Vincent, Benjamin Matteson
Langlois, Jean-Baptiste
Tidor, Bruce
Buchwald, Stephen Leffler
Lindquist, Susan
author_sort Srinivas, Raja
collection MIT
description To cause disease, a microbial pathogen must adapt to the challenges of its host environment. The leading fungal pathogen Candida albicans colonizes nutrient-poor bodily niches, withstands attack from the immune system, and tolerates treatment with azole antifungals, often evolving resistance. To discover agents that block these adaptive strategies, we screened 300,000 compounds for inhibition of azole tolerance in a drug-resistant Candida isolate. We identified a novel indazole derivative that converts azoles from fungistatic to fungicidal drugs by selective inhibition of mitochondrial cytochrome bc1. We synthesized 103 analogs to optimize potency (half maximal inhibitory concentration 0.4 μM) and fungal selectivity (28-fold over human). In addition to reducing azole resistance, targeting cytochrome bc₁ prevents C. albicans from adapting to the nutrient-deprived macrophage phagosome and greatly curtails its virulence in mice. Inhibiting mitochondrial respiration and restricting metabolic flexibility with this synthetically tractable chemotype provides an attractive therapeutic strategy to limit both fungal virulence and drug resistance.
first_indexed 2024-09-23T12:06:04Z
format Article
id mit-1721.1/111146
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T12:06:04Z
publishDate 2017
publisher Elsevier
record_format dspace
spelling mit-1721.1/1111462022-09-28T00:10:06Z A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance Srinivas, Raja Lancaster, Alex K. Scherz-Shouval, Ruth Whitesell, Luke Vincent, Benjamin Matteson Langlois, Jean-Baptiste Tidor, Bruce Buchwald, Stephen Leffler Lindquist, Susan Massachusetts Institute of Technology. Department of Biological Engineering Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Chemistry Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Vincent, Benjamin Matteson Langlois, Jean-Baptiste Tidor, Bruce Buchwald, Stephen Leffler Lindquist, Susan To cause disease, a microbial pathogen must adapt to the challenges of its host environment. The leading fungal pathogen Candida albicans colonizes nutrient-poor bodily niches, withstands attack from the immune system, and tolerates treatment with azole antifungals, often evolving resistance. To discover agents that block these adaptive strategies, we screened 300,000 compounds for inhibition of azole tolerance in a drug-resistant Candida isolate. We identified a novel indazole derivative that converts azoles from fungistatic to fungicidal drugs by selective inhibition of mitochondrial cytochrome bc1. We synthesized 103 analogs to optimize potency (half maximal inhibitory concentration 0.4 μM) and fungal selectivity (28-fold over human). In addition to reducing azole resistance, targeting cytochrome bc₁ prevents C. albicans from adapting to the nutrient-deprived macrophage phagosome and greatly curtails its virulence in mice. Inhibiting mitochondrial respiration and restricting metabolic flexibility with this synthetically tractable chemotype provides an attractive therapeutic strategy to limit both fungal virulence and drug resistance. National Institutes of Health (U.S.) (GM46059) 2017-09-07T15:48:36Z 2017-09-07T15:48:36Z 2016-08 2016-05 Article http://purl.org/eprint/type/JournalArticle 2451-9456 http://hdl.handle.net/1721.1/111146 Vincent, Benjamin M. et al. “A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance.” Cell Chemical Biology 23, 8 (August 2016): 978–991 © 2016 Elsevier Ltd https://orcid.org/0000-0002-3320-3969 https://orcid.org/0000-0003-3875-4775 https://orcid.org/0000-0003-1307-882X en_US http://dx.doi.org/10.1016/j.chembiol.2016.06.016 Cell Chemical Biology Creative Commons Attribution-NonCommercial-NoDerivs License http://creativecommons.org/licenses/by-nc-nd/4.0/ application/pdf Elsevier PMC
spellingShingle Srinivas, Raja
Lancaster, Alex K.
Scherz-Shouval, Ruth
Whitesell, Luke
Vincent, Benjamin Matteson
Langlois, Jean-Baptiste
Tidor, Bruce
Buchwald, Stephen Leffler
Lindquist, Susan
A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
title A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
title_full A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
title_fullStr A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
title_full_unstemmed A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
title_short A Fungal-Selective Cytochrome bc₁ Inhibitor Impairs Virulence and Prevents the Evolution of Drug Resistance
title_sort fungal selective cytochrome bc₁ inhibitor impairs virulence and prevents the evolution of drug resistance
url http://hdl.handle.net/1721.1/111146
https://orcid.org/0000-0002-3320-3969
https://orcid.org/0000-0003-3875-4775
https://orcid.org/0000-0003-1307-882X
work_keys_str_mv AT srinivasraja afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT lancasteralexk afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT scherzshouvalruth afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT whitesellluke afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT vincentbenjaminmatteson afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT langloisjeanbaptiste afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT tidorbruce afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT buchwaldstephenleffler afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT lindquistsusan afungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT srinivasraja fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT lancasteralexk fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT scherzshouvalruth fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT whitesellluke fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT vincentbenjaminmatteson fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT langloisjeanbaptiste fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT tidorbruce fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT buchwaldstephenleffler fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance
AT lindquistsusan fungalselectivecytochromebc1inhibitorimpairsvirulenceandpreventstheevolutionofdrugresistance